Published: Mar 03, 2021, 20:33 IST | Updated: Mar 03, 2021, 20:33 IST
Bharat Biotech has announced the Phase 3 clinical trial results for its Coronavirus vaccine candidate Covaxin. The company said that Covaxin demonstrated an efficacy of 81 per cent in the trials.